HLA-C and COVID-19: In conclusion, our results pointed out the reduction of HLA-C expression in COVID-19 patients, more pronounced in the severe cases, suggesting this molecule involved in antigen presentation as a potential prognostic marker and therapeutic target in RNA virus infections.